GLUD1 抗体 (AA 210-558)
Our Local Distributor
北京 101111
Quick Overview for GLUD1 抗体 (AA 210-558) (ABIN7872185)
抗原
See all GLUD1 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 210-558
-
原理
- GLUD1 Antibody / Glutamate dehydrogenase 1
-
纯化方法
- Immunogen affinity purified
-
免疫原
- E.coli-derived human GLUD1 recombinant protein (Position: A210-T558) was used as the immunogen for the GLUD1 antibody.
-
亚型
- IgG
-
-
-
-
应用备注
- Optimal dilution of the GLUD1 antibody should be determined by the researcher.
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL
-
缓冲液
- Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- After reconstitution, the GLUD1 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
-
-
- GLUD1 (Glutamate Dehydrogenase 1 (GLUD1))
-
别名
- GLUD1
-
背景
-
GLUD1 antibody detects Glutamate dehydrogenase 1, a mitochondrial enzyme that catalyzes the reversible oxidative deamination of glutamate to alpha-ketoglutarate and ammonia. The UniProt recommended name is Glutamate dehydrogenase 1, mitochondrial (GLUD1). This enzyme connects amino acid metabolism to the tricarboxylic acid (TCA) cycle, serving as a key regulator of nitrogen balance and cellular energy production.
Functionally, GLUD1 antibody identifies a 558-amino-acid enzyme located in the mitochondrial matrix. GLUD1 catalyzes the interconversion of glutamate and alpha-ketoglutarate with the reduction or oxidation of NAD(P)+ cofactors. This reaction controls the flow of carbon and nitrogen through metabolic networks, linking amino acid catabolism, the TCA cycle, and oxidative phosphorylation. In the brain, GLUD1 contributes to the glutamate-glutamine cycle, influencing neurotransmitter turnover and synaptic function.
The GLUD1 gene is located on chromosome 10q23.3 and encodes a hexameric enzyme regulated allosterically by ADP, GTP, leucine, and other metabolites. GLUD1 activity increases during energy demand, providing substrates for ATP synthesis, while its inhibition by GTP prevents excessive ammonia production. Mutations in GLUD1 cause hyperinsulinism-hyperammonemia (HI/HA) syndrome, characterized by dysregulated insulin secretion due to elevated oxidative deamination in pancreatic beta cells.
In hepatic tissue, GLUD1 participates in ammonia detoxification and urea synthesis by controlling the balance between glutamate oxidation and synthesis. In pancreatic islets, its activity modulates insulin release in response to amino acids. In neurons, GLUD1 provides energy intermediates and regulates excitatory neurotransmission. Dysregulation of GLUD1 is implicated in neurodegenerative diseases, metabolic syndromes, and hyperinsulinemic disorders.
GLUD1 antibody is widely used in research involving metabolism, neurobiology, and endocrinology. It is suitable for immunoblotting, immunofluorescence, and enzyme localization studies to assess mitochondrial distribution and activity. This antibody enables detection of GLUD1 in tissues such as liver, brain, and pancreas, where it plays distinct metabolic roles. In cancer research, GLUD1 expression correlates with metabolic reprogramming, supporting tumor cell growth through glutamine oxidation.
Structurally, GLUD1 forms a hexameric complex with alternating catalytic and regulatory domains. The enzyme's activity is modulated by phosphorylation, redox state, and energy charge. NSJ Bioreagents provides GLUD1 antibody reagents validated for use in mitochondrial metabolism, neurochemistry, and metabolic disease research. -
UniProt
- P00367
-
途径
- Positive Regulation of Peptide Hormone Secretion, Warburg Effect
抗原
-